» Articles » PMID: 8385575

Enhanced Immunosuppressive Activity Associated with Metastatic Lymphoma Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 1993 Apr 15
PMID 8385575
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Earlier reports from our laboratory showed that Abelson virus-induced, highly malignant and liver metastatic RAW117-H10 cells, but not the parental, less metastatic RAW117-P cells, inhibited both T-cell and B-cell mitogen-induced proliferation of syngeneic normal murine spleen cells. Similar inhibition was also noted when RAW117-H10 cell surface molecules extracted with butanol were used instead of whole tumor cells. In this report we describe the suppressive properties of the butanol-extracted RAW117-H10 cell surface molecules on other immune functions and the isolation/purification of a molecule from RAW117-H10 cell butanol extract which shows inhibitory activity. The immunosuppressive molecules also inhibit natural killer cell-mediated cytotoxicity, lymphokine-activated killer cell-mediated cytotoxicity, and bone marrow colony-forming unit-granulocyte-macrophage colony formation, but not colony-forming unit-fibroblast colony formation. The suppressive molecules inhibit interleukin 2 production by the T-lymphocytes. One of the molecules responsible for some of the immunosuppressive activity has been isolated and purified from butanol extracts of the metastatic RAW117-H10 cells by preparative isoelectrofocusing techniques. The suppressive molecule has an isoelectric point of 4.3 with an approximate molecular weight of 70,000. Metastatic RAW117-H10 lymphoma cells therefore express immunosuppressive molecules, which may facilitate their growth and metastasis in vivo.

Citing Articles

Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Lokhov P, Balashova E J Cancer. 2010; 1:230-41.

PMID: 21151581 PMC: 3001283. DOI: 10.7150/jca.1.230.


Interleukin-2 therapy of lymphoma-bearing immunosuppressed mice.

Joshi S, Messbarger L, Hao W Clin Exp Metastasis. 1994; 12(1):37-46.

PMID: 8287619 DOI: 10.1007/BF01784332.